Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide
5-hydroxythalidomide is a primary thalidomide metabolite generated by the cytochrome P450 isozymes. The reported data, including crystal structure of the 5-hydroxythalidomide-mediated complex of CRBN with SALL4, elucidate how additional hydroxy group of the metabolite enhances the interaction of CRB...
Enregistré dans:
Auteurs principaux: | Hirotake Furihata, Satoshi Yamanaka, Toshiaki Honda, Yumiko Miyauchi, Atsuko Asano, Norio Shibata, Masaru Tanokura, Tatsuya Sawasaki, Takuya Miyakawa |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e6839866ce1b4a9fbf178c9bea0007d2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Agentes inmunomoduladores (IMiDs): herramientas para el tratamiento del mieloma múltiple
par: Fernández-Lázaro,Diego, et autres
Publié: (2018) -
pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase
par: Jian An, et autres
Publié: (2017) -
NMR-based metabolomics for simultaneously evaluating multiple determinants of primary beef quality in Japanese Black cattle
par: Yoshinori Kodani, et autres
Publié: (2017) -
Gdzie walczył i jak miał na imię brat Mieszka I?
par: Michał Łuczyński
Publié: (2020) -
A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
par: Vered Schechner, et autres
Publié: (2021)